Cost-Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.765
https://www.valueinhealthjournal.com/article/S1098-3015(17)31099-9/fulltext
Section Title :
Disease-Specific Studies
Section Order :
731
First Page :
A534
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31099-9&doi=10.1016/j.jval.2017.08.765